Policyholder

In insurance, a policyholder is a person or entity who owns an insurance policy and is entitled to its benefits. The policyholder is typically the person who pays the premiums and is listed as the policyholder on the insurance policy.

 

Here is an example of a policyholder:

 

John Smith purchases a life insurance policy from ABCInsurance Company. John is the policyholder and is responsible for paying the premiums. If John were to pass away while the policy is in force, his beneficiaries would receive the death benefit.

 

Key features of a policyholder in insurance include:

 

·      The policyholder is the person or entity who owns the insurance policy and pays the premiums.

·      The policyholder is entitled to the benefits of the insurance policy, including any payouts or coverage.

·      The policyholder may be an individual, such asJohn Smith in the example above, or it may be an organization, such as a business that purchases group insurance for its employees.

·      The policyholder has certain responsibilities, such as paying premiums on time, providing accurate information to the insurance company, and notifying the insurer of any changes that may affect the policy.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.